Skip to main content
Earnings Labs
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$41.72

+0.07%

Mkt Cap $2.53B

EPS — Estimate vs Actual

Mkt Cap

$2.53B

P/E

Fwd P/E

25.99

P/S

3.25

Rev TTM

EPS TTM

-$0.51